View all cases
UPC CFI 11/2025
Jan 20, 2025·EP2196231: System for ambulatory drug infusion comprising a filling apparatus for flexible containers
- Case details
- StatusCase ClosedActionGenericCategoryGeneric
- Parties
- Division
- Paris CD
- Technology
- Pharmaceutical & Medical
- Language
- English
Documents
| Document title | Date | Public |
|---|---|---|
| Final order 831-25 anonymized | 2025-04-30 | Not public |
| Final order - app for a cost decision 831-25 | 2025-04-30 | Not public |
| Headnote-and-Keywords | 2025-04-29 | Not public |
| Application-For-Costs-Decision-Outcome | 2025-04-29 | Not public |
| cost decision | 2025-04-29 | Public |
| cost decision | 2025-04-29 | Not public |
| cost decision | 2025-04-29 | Public |
| cost decision | 2025-04-29 | Not public |
| Comments Cost Application | 2025-03-21 | Not public |
| Comments Cost Application | 2025-03-21 | Not public |
| Final order anonymized 06.03.2025 | 2025-03-10 | Not public |
| preliminary order | 2025-03-06 | Not public |
| rule 262A | 2025-03-06 | Public |
| rule 262A | 2025-03-06 | Not public |
| Exhibit KAP KFA 17 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 06 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 13 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 18 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 14 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 09 - Redacted | 2025-03-04 | Not public |
| 2025-01-20 Application for a cost decision Roche_redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 08 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 11 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 04 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 19 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 03 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 01 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 07 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 10 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 15 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 12 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 02 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 05 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 16 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 16 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 02 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 06 -EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 11 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 15 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 19 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 17 -EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 01 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 07 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 13 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 05 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| 2025-03-04 Submission Roche | 2025-03-04 | Not public |
| Exhibit KAP KFA 08 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 03 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 04 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 12 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 09 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 14 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 10 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 18 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Preliminary order anonymized - 3143/2025 | 2025-02-26 | Not public |
| Outcome of the Order | 2025-02-25 | Not public |
| rule 262 (A) | 2025-02-25 | Not public |
| rule 262 (A) | 2025-02-25 | Public |
| Response to Order of the Court - Comments to Application pursuant to Rule 262A | 2025-02-13 | Not public |
| Response to Order of the Court - Comments to Application pursuant to Rule 262A | 2025-02-13 | Not public |
| Exhibit KAP KFA 15 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 19 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 07 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 03 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 05 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 08 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| 2025-01-20 Application for a cost decision Roche_STRICTLY CONFIDENTIAL | 2025-02-03 | Not public |
| Exhibit KAP KFA 06 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 14 - EN _STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 04 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| 2025-02-03 Brief Roche regarding submission confidential documents_signed | 2025-02-03 | Not public |
| Exhibit KAP KFA 01 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 09 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 11 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 02 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 17 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 12 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 18 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 10 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 13 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 16 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Preliminary order anonymized 29.01.2025 | 2025-01-29 | Not public |
| rule 262 (A) | 2025-01-29 | Public |
| rule 262 (A) | 2025-01-29 | Not public |
| Panel-Appointment | 2025-01-20 | Not public |
| Receipt | 2025-01-20 | Not public |
| Receipt | 2025-01-20 | Not public |
| 2025-01-20 Application for confidentiality R 262A_signed | 2025-01-20 | Not public |
| 2025-01-20 Application for confidentiality R 262_2_signed | 2025-01-20 | Not public |
| Acknowledgement-of-lodging | 2025-01-20 | Not public |
| Exhibit KAP KFA 13 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 06 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 14 - EN _STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 09 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 17 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 02 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| 2025-01-20 Application for a cost decision Roche_STRICTLY CONFIDENTIAL_signed | 2025-01-20 | Not public |
| Exhibit KAP KFA 08 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 11 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 03 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 20 - DE.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 17 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 05 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 06 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 13 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 12 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 16 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 21 - EN.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 03 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 05 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 16 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 09 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 10 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 07 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 11 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 04 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 14 - EN _STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 18 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 15 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 25 - DE.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 04 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| 2025-01-20 Application for a cost decision Roche_STRICTLY CONFIDENTIAL_signed | 2025-01-20 | Not public |
| Exhibit KAP KFA 24 - DE.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 19 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 02 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 08 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 07 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 23 - DE.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 05 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 12 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 19 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 22 - DE.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 10 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 15 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 02 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| 2025-01-20 Application for a cost decision Roche_STRICTLY CONFIDENTIAL_signed | 2025-01-20 | Not public |
| Exhibit KAP KFA 09 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 01 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 18 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 18 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 17 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 01 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 11 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 01 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 15 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 19 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 10 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 03 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 16 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 13 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 08 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 12 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 14 - EN _STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 04 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 06 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 07 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |